BlackDoctor6d
This Clinical Trial Is Making HIV Treatment Easier for Black People
The BRAAVE2020 study investigated the efficacy of switching Black Americans living with HIV to a B/F/TAF single-pill regimen.
GlobalData on MSN1d
ViiV Healthcare shares results from trial of Dovato and three-drug therapy for HIV
The study evaluated the efficacy and safety of Dovato in 230 antiretroviral treatment-naïve individuals with advanced HIV.
sinchew1d
Immuno Cure Biotech Presents Promising Results on Phase I Clinical Trial of a Therapeutic HIV DNA Vaccine
Immuno Cure’s ICVAX aims to induce broadly reactive polyfunctional viral-specific T cells to achieve sustained HIV-1 ...
Study links historical redlining to delays in HIV treatment
A new study from Tulane University finds that historical race-based lending practices are still impacting health today, ...
Scientific Leadership Spotlighted as Gilead Presents Research Data Across Its Broad and Innovative HIV Treatment Portfolio and Pipeline
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of new research data from its innovative HIV treatment ...
DutchNews.NL1d
Code Pharma’s Gammora® Demonstrates Highly Favorable Outcomes Toward a Potential Cure for HIV
Due to positive results, the trial will conclude earlier than expected, reducing the number of recruitments. “These findings ...
Los Angeles Times6h
Working to End the HIV Epidemic Through Innovation, Equity, Collaboration & Choice
Gilead is committed to designing trials to help understand how HIV treatment and prevention impact populations that have been ...
Gilead to present HIV research findings at conference
Gilead (GILD) announced the upcoming presentation of HIV research findings at the International Congress on Drug Therapy in HIV Infection, ...
News Medical on MSN1d
Historical redlining continues to affect HIV treatment in affected communities
A new study from Tulane University finds that historical race-based lending practices are still impacting health today, linking these discriminatory policies to delays in effective HIV treatment ...